Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease. SciELO Preprints. julho 22, 2025. https://doi.org/10.1590/SciELOPreprints.12615.